Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9735-40.

Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation.

Author information

1
Center for Clinical and Molecular Neurobiology Departments of Neurology, University of Minnesota, Minneapolis 55455, USA.

Abstract

Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide (Abeta), play a critical role in the pathogenesis of Alzheimer's dementia. We report that transgenic mice overexpressing APP and Abeta have a profound attenuation in the increase in neocortical blood flow elicited by somatosensory activation. The impairment is highly correlated with brain Abeta concentration and is reproduced in normal mice by topical neocortical application of exogenous Abeta1-40 but not Abeta1-42. Overexpression of M146L mutant presenilin-1 in APP mice enhances the production of Abeta1-42 severalfold, but it does not produce a commensurate attenuation of the hyperemic response. APP and Abeta overexpression do not diminish the intensity of neural activation, as reflected by the increase in somatosensory cortex glucose usage. Thus, Abeta-induced alterations in functional hyperemia produce a potentially deleterious mismatch between substrate delivery and energy demands imposed by neural activity.

PMID:
10944232
PMCID:
PMC16934
DOI:
10.1073/pnas.97.17.9735
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center